FDA Brief

Warning letters Drugs

FDA warning letter to

Grupo Plast-Y-Kosas, SA de CV

High riskIssued Jan 25, 2021Posted Jan 26, 2021Center for Drug Evaluation and Research | CDER

FDA found methanol in M Hand Sanitizer and low ethanol in two other hand sanitizers labeled as made by Grupo Plast-Y-Kosas.

What happened

FDA laboratory-tested hand sanitizers labeled as manufactured at the firm's Reynosa, Mexico facility after they were detained and refused admission at the U.S. border. M HAND SANITIZER was labeled 80% ethanol but contained 0.87% ethanol and 15% methanol; Jalisco Paper Inc. and O.K. PHARMACY hand sanitizers were labeled 80% ethanol but contained 8.6% and 9.2% ethanol. FDA had placed the firm's drugs on Import Alert 66-78 (a border detention list), and the firm recalled M HAND SANITIZER in September 2020.

What FDA found

  1. M HAND SANITIZER was labeled to contain 80% ethanol but FDA testing found 0.87% ethanol and 15% methanol, meaning the ethanol was replaced with a dangerous chemical.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. Jalisco Paper Inc. HAND SANITIZER and O.K. PHARMACY HAND SANITIZER were labeled 80% ethanol but tested at 8.6% and 9.2% ethanol, so their strength was below what the labels said.

    FD&C Act section 501(c), 21 U.S.C. 351(c)
  3. Because of the methanol substitution and low ethanol strength, FDA said the firm's quality assurance was not working under current good manufacturing practice (CGMP).

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  4. The hand sanitizers are unapproved new drugs (marketed without FDA approval) because they lack FDA approval and do not meet the conditions for marketing without approval.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  5. The labels were false and misleading because they stated 80% ethanol when tests found much less, and M HAND SANITIZER did not declare methanol.

    FD&C Act sections 502(a) and 502(e), 21 U.S.C. 352(a) and 352(e)
  6. M HAND SANITIZER is dangerous when used as labeled and does not meet the nonprescription drug marketing requirements, so its labeling is unlawful.

    FD&C Act sections 502(j) and 502(ee), 21 U.S.C. 352(j) and 352(ee)

What FDA wants

FDA asks the firm to investigate the methanol substitution and low ethanol strength, list all raw materials and suppliers and all U.S.-shipped batches with reconciliation, and provide complete batch records. The firm must respond in writing within 15 working days; if corrective actions cannot be completed, it must give reasons and a completion schedule.

Who should pay attention

  • brands and distributors that buy hand sanitizer from this manufacturer
  • U.S. importers and retailers selling Mexican hand sanitizers
  • consumers using alcohol-based hand sanitizer, especially children

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk